Semi-Annual Consolidated Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7252924

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
60,563,000,000 JPY
55,407,000,000 JPY
Cost of sales
44,030,000,000 JPY
41,568,000,000 JPY
Ordinary profit (loss)
3,780,000,000 JPY
1,868,000,000 JPY
Gross profit (loss)
16,532,000,000 JPY
13,838,000,000 JPY
Extraordinary income
JPY
39,000,000 JPY
Selling, general and administrative expenses
Salaries
2,363,000,000 JPY
2,354,000,000 JPY
Depreciation
342,000,000 JPY
321,000,000 JPY
Selling, general and administrative expenses
12,401,000,000 JPY
11,874,000,000 JPY
Extraordinary losses
8,751,000,000 JPY
140,000,000 JPY
Profit (loss) before income taxes
-4,970,000,000 JPY
1,767,000,000 JPY
Operating profit (loss)
4,131,000,000 JPY
1,964,000,000 JPY
Income taxes - current
1,029,000,000 JPY
425,000,000 JPY
Non-operating income
Non-operating income
235,000,000 JPY
232,000,000 JPY
Income taxes - deferred
-2,711,000,000 JPY
-35,000,000 JPY
Non-operating expenses
Interest expenses
161,000,000 JPY
171,000,000 JPY
Non-operating expenses
586,000,000 JPY
328,000,000 JPY
Income taxes
-1,682,000,000 JPY
389,000,000 JPY
Profit (loss)
-3,288,000,000 JPY
-3,288,000,000 JPY
-3,288,000,000 JPY
-3,288,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
1,377,000,000 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.